Berardis, Domenico de
Melatonin, Neuroprotective Agents and Antidepressant Therapy
1. History of Pineal Gland as Neuroendocrine Organ and the Discovery of Melatonin
Francisco López-Muñoz, Fernando Marín, Cecilio Álamo
2. Bibliometric Study of Scientific Research on Melatonin During the Last 25 Years
Francisco López-Muñoz, Francisco J. Povedano, Cecilio Álamo
3. Neuroimaging of the Pineal Gland: Focus on Primary Insomnia
J. M. Bumb, Ingo S. Nölte
4. Melatonin: Basic and Clinical Aspects
Agata Carpentieri, Vanessa Areco, Gabriela Díaz Barboza, María Angélica Rivoira, Solange Guizzardi, Nori Tolosa Talamoni
5. Melatonin and Melatonin Receptors in Neuroprotection
Omur Gulsum Deniz, Aysın Pınar Turkmen, Mehmet Emin Onger, Berrin Zuhal Altunkaynak, Suleyman Kaplan
6. Melatonin Supplementation in Neurodegenerative Diseases: Current Status
Giovanni Polimeni, Claudio Guarneri, Salvatore Cuzzocrea
7. Therapeutic Potential of Melatonin in Combination with Other Drugs Against Neurodegeneration
Eva Ramos, Paloma Patiño, José Luis Marco-Contelles, Ramón Cacabelos, Alejandro Romero
8. Melatonin, a Neuroprotective Agent: Relevance for Stress-Induced Neuropsychiatric Disorders
Piyarat Govitrapong, Kasima Ekthuwapranee, Nootchanart Ruksee, Parichart Boontem
9. Melatonin, Sleep, Circadian Rhythm, and Mood Disorders
Venkataramanujam Srinivasan, Domenico Berardis, Michele Fornaro, Francisco López-Muñoz, Timo Partonen, Rahimah Zakaria
10. Melatonin Induces Antidepressant-Like Behavior by Promotion of Adult Hippocampal Neurogenesis
Gerardo Bernabé Ramírez-Rodríguez
11. Association Between Melatonin and Neuroimmune Diseases
Murat Terzi, Mehmet Emin Onger, Aysin Pınar Turkmen, Sefa Ersan Kaya, Arife Ahsen Kaplan, Berrin Zuhal Altunkaynak, Suleyman Kaplan
12. Melatonin in Clinical Status of Patients with Fibromyalgia Syndrome
Andrei Pereira Pernambuco, Marina Barros Pinheiro, Débora Ávila Reis
13. Melatonin’s Beneficial Effects in Hepatic Injury
Pınar Atukeren, Hafize Uzun
14. Melatonin as a Novel Therapeutic Agent Against Chemical Warfare Agents
René Pita, Eva Ramos, José Luis Marco-Contelles, Alejandro Romero
15. New Galenic Formulations of Melatonin
Pilar García-García, Francisco López-Muñoz, Cecilio Álamo
16. Melatonergic Drug Ramelteon in Neurotherapeutics
Venkataramanujam Srinivasan, Rahimah Zakaria, Domenico Berardis, Francisco López-Muñoz, Mohd Jamil Yaacob, Zahiruddin Othman, Amnon Brzezinski
17. Melatonergic Antidepressant Agomelatine and Its Efficacy in Depressive Disorders
Venkataramanujam Srinivasan, Domenico Berardis, Michele Fornaro, Francisco Lopez-Muñoz, Rahimah Zakaria, Mohd Jamil Yaacob, Zahiruddin Othman
18. Agomelatine, Melatonin and Depression
Trevor R. Norman
19. Neuropsychological Models of Depression
Stephan Moratti, Alberto Fernández, Rosa Jurado, Gabriel Rubio
20. Chronobiology of Mood Disorders
Felice Iasevoli, Livia Avvisati, Valentina Gilardi, Gianmarco Latte, Emiliano Prinzivalli, Domenico Berardis, Alessandro Valchera, Michele Fornaro, Carmine Tomasetti, Andrea Bartolomeis
21. Bipolar Disorders and Biological Rhythms
Robert Gonzalez
22. Circadian Clock Genes and Mood Disorders
Timo Partonen
23. Understanding the Biologically Adaptive Side of Mood Disorders: A Focus on Affective Temperaments
Xenia Gonda, Gustavo H. Vazquez
24. Sleep Abnormalities as a Diagnostic Tool for Major Depressive Disorder
Alan B. Douglass, Marcus Ward, Timothy Roerhrs, Cynthia L. Arfken, Nash N. Boutrous
25. Depression: Correlations with Thyroid Hormones in Major Depressive Disorder
Dominika Berent
26. History of the Discovery of Antidepressant Drugs
Francisco López-Muñoz, Cecilio Álamo
27. Neurocognitive Deficit in Bipolar Disorders
Dimos Dimelis, Xenia Gonda, Konstantinos N. Fountoulakis
28. Combination Strategies in Treatment-Resistant Depression
Francisco López-Muñoz, Cecilio Álamo, Pilar García-García
29. Antidepressant Drugs in Elderly
Cecilio Álamo, Francisco López-Muñoz, Pilar García-García
30. Antidepressant Efficacy of Escitalopram in Major Depressive Disorder
Eiji Kirino
31. Antidepressant Medications and Suicide Risk: What Was the Impact of FDA Warning?
Gianluca Serafini, Paola Solano, Mario Amore
32. Neurobiology and Pharmacological Prevention of Suicide in Mood Disorders
Xenia Gonda, Zoltan Rihmer, Peter Dome
33. Antidepressant and Anticonvulsant Drugs as Adjuvant Analgesics in Chronic Pain
Manuel Sebastián-Aldeanueva, Francisco López-Muñoz, José Antonio Guerra, Cecilio Álamo
34. Genetic Polymorphisms of Cytochrome P450 and Antidepressants
Ana Isabel Wu-Chou, Yu-Li Liu, Winston W. Shen
35. Pharmacogenomics of Antidepressant Drugs
Ramón Cacabelos, Clara Torrellas, Francisco López-Muñoz
36. Antidepressants Modulate Microglia Beyond the Neurotransmitters Doctrine of Mood Disorders
Masahiro Ohgidani, Takahiro A. Kato, Yoshito Mizoguchi, Hideki Horikawa, Akira Monji, Shigenobu Kanba
37. Brain-Derived Neurotrophic Factor (BDNF): TrkB Signaling in Depression – Biomarker and Novel Therapeutic Target
Kenji Hashimoto
38. Targeting Opioid Receptors for Innovative Antidepressant Therapies: Rediscovering the Opioid Cure
Emmanuel Darcq, Paul Chu-Sin-Chung, Brigitte L. Kieffer, Pierre-Eric Lutz
39. Prolactin and Somatostatin Responses to Antidepressant Therapy
Agata Faron-Górecka, Kinga Szafran-Pilch
40. The Role of Vasopressin in Anxiety and Depression
Julio Cesar Morales-Medina, Shannah K. Witchey, Heather K. Caldwell
41. Ketamine: The Glutamatergic Antidepressant and Its Efficacy
Derek K. Tracy, Caroline Caddy, Sukhwinder S. Shergill
42. Acetylcholinergic Nicotinic Receptors as Pharmacological Targets for Cognitive Enhancement: Emerging Evidence from Psychosis Populations
Derek K. Tracy, Valentina Casetti, Arann R. Rowe, Louise Mercer, Sukhwinder S. Shergill
43. The Glutamate mGluR5 Receptor as a Pharmacological Target to Enhance Cognitive Function: Emerging Evidence from Psychosis Models
Derek K. Tracy, Nicola Smallcombe, Farah Tiwana, Judith Fosbraey, Kyra-Verena Sendt, Sukhwinder S. Shergill
44. Corticotropin-Releasing Factor Receptors as a Potential Target in the Developments of Antidepressant Drugs
Glenn R. Valdez
45. Nitric Oxide Signaling in Depression and Antidepressant Action
Gregers Wegener, Sâmia R. L. Joca
46. The Role of Arrestins in the Neuroprotective Effects of Antidepressant Drugs
Sofia Avissar, Moran Golan, Valeria Feinshtein, Siyona Kolatkar, Doron Fux, Gabriel Schreiber
47. Antidepressant Drugs and Phosphodiesterases
Zhuoyou Chen, Xifei Yang, Ying Xu, Han-Ting Zhang
48. Effects of Methylphenidate and Atomoxetine on Development of the Brain
Berrin Zuhal Altunkaynak, Mehmet Emin Onger, Aysin Pınar Turkmen, Kıymet Kubra Yurt, Gamze Altun, Murat Yuce, Suleyman Kaplan
49. S-Adenosyl-L-Methionine for Major Depressive Disorder
Domenico Berardis, Laura Orsolini, Felice Iasevoli, Carmine Tomasetti, Monica Mazza, Alessandro Valchera, Michele Fornaro, Giampaolo Perna, Monica Piersanti, Marco Nicola, Giovanni Martinotti, Francisco López-Muñoz, Massimo Giannantonio
50. The Role of Antiepileptic Drugs in Bipolar Depression
Juan D. Molina, Manuel Durán, Francisco López-Muñoz, Cecilio Álamo, Francisco Toledo-Romero
51. Melatonin and Other Neuroprotective Agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis
Anastasios Fotinos, Yongjin Zhu, Lilly L. J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz, Xin Wang
Nyckelord: Medicine & Public Health, Neurology, Psychopharmacology, Internal Medicine
- Utgivare
- Berardis, Domenico de
- Kato, Takahiro A.
- López-Muñoz, Francisco
- Srinivasan, Venkataramanujam
- Álamo, Cecilio
- Utgivare
- Springer
- Utgivningsår
- 2016
- Språk
- en
- Utgåva
- 1
- Sidantal
- 25 sidor
- Kategori
- Hälsa, skönhet, mode
- Format
- E-bok
- eISBN (PDF)
- 9788132228035
- Tryckt ISBN
- 978-81-322-2801-1